Of the 3853 female patients newly diagnosed with stage II or III HER2-negative primary invasive breast cancer for whom ER and PR continuous expression data were available, 3055 patients met the study criteria included in the analysis (Supplementary Fig. S1). Here, PGR is linked to invasive breast carcinoma.